In PepBank now:147 peptides, 6 blends and 13 other compounds97,577 study results from 17,383 studies8,473 clinical trialsUpdated
PepBank shows no results on Oxyntomodulin (human) from studies in people, animals, the lab or computer predictions. Data as of 2026-10-30.
Also known as OXM, Enteroglucagon, Oxyntomodulin, Glicentin (33-69), Glucagon (1-37), Proglucagon (33-69)
| What it is | Natural peptide, 37 amino acids |
|---|---|
| Approval | Not approved for any use |
| In sport | Not named on the List; S0 may still apply (no approval anywhere) |
| Studies | No study results for Oxyntomodulin (human) yet |
| Clinical trials | 2 registered: 0 active or planned, 1 with posted results |
Endogenous 37-residue peptide cleaved from proglucagon that activates GLP-1 and glucagon receptors. Reference record; not a medicine.
Amino acids in one chain
The key facts about the molecule. Long codes are in the closed section below.
Curo is a peptide shop. PepBank and Curo have the same owner. See the Curo catalog (opens in a new tab).
Three-letter sequenceH-His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr-Lys-Arg-Asn-Arg-Asn-Asn-Ile-Ala-OH
InChIKeyDDYAPMZTJAYBOF-ZMYDTDHYSA-N
SMILESCC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC5=CC=C(C=C5)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC6=CC=CC=C6)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC7=CNC=N7)N
Results grouped by what the studies measured. Each card shows where its results come from.
ClinicalTrials.gov lists 2 trials of Oxyntomodulin (human). 0 are active or planned, and 1 has posted results. PepBank does not show trial results.
Solid bars are dates that happened. Hatched bars are planned dates. Data from ClinicalTrials.gov.
No approved medicine contains it.
No approved medicine contains it.
Not named on the List. Section S0 covers substances with no approval.
No. Not approved for any use. Its most advanced trial is in phase 1. The FDA, the EMA and the other sources we use show no approval (as of 8 Oct 2026). Not named on the List; S0 may still apply (no approval anywhere).
Laws and labels change, so check the regulator for the current status.
PepBank has no safety result from studies of Oxyntomodulin (human) yet. That does not mean Oxyntomodulin (human) is safe.
The answer links to every study it uses.
AI wrote and checked these results. AI can make mistakes, so check important results against the source.
PepBank is a research reference. Talk to a doctor before you use any peptide.